BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17287409)

  • 21. Growth hormone treatment of short children born small for gestational age: growth responses with continuous and discontinuous regimens over 6 years.
    de Zegher F; Albertsson-Wikland K; Wollmann HA; Chatelain P; Chaussain JL; Löfström A; Jonsson B; Rosenfeld RG
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2816-21. PubMed ID: 10946888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive and psychosocial development concerns in children born small for gestational age.
    Lee PA; Houk CP
    Pediatr Endocrinol Rev; 2012 Dec-2013 Jan; 10(2):209-16. PubMed ID: 23539832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GH responsiveness in a large multinational cohort of SGA children with short stature (NESTEGG) is related to the exon 3 GHR polymorphism.
    Tauber M; Ester W; Auriol F; Molinas C; Fauvel J; Caliebe J; Nugent T; Fryklund L; Ranke MB; Savage MO; Clark AJ; Johnston LB; Hokken-Koelega AC;
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):457-61. PubMed ID: 17555507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased proportion of circulating non-22-kilodalton growth hormone isoforms in short children: a possible mechanism for growth failure.
    Boguszewski CL; Jansson C; Boguszewski MC; Rosberg S; Carlsson B; Albertsson-Wikland K; Carlsson LM
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2944-9. PubMed ID: 9284724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, dose-response trial.
    Sas T; de Waal W; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3064-70. PubMed ID: 10487666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-year growth response to growth hormone treatment in very young children born small for gestational age-data from KIGS.
    Boguszewski MC; Lindberg A; Wollmann HA
    J Clin Endocrinol Metab; 2014 Aug; 99(8):2683-8. PubMed ID: 24758180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
    Van Pareren Y; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive ability in adolescents born small for gestational age: Associations with fetal growth velocity, head circumference and postnatal growth.
    Jensen RB; Juul A; Larsen T; Mortensen EL; Greisen G
    Early Hum Dev; 2015 Dec; 91(12):755-60. PubMed ID: 26411400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age.
    Bannink EM; van Doorn J; Mulder PG; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2992-3000. PubMed ID: 17504895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health-related quality of life in short children born small for gestational age: effects of growth hormone treatment and postponement of puberty.
    Lem AJ; Jobse I; van der Kaay DC; de Ridder MA; Raat H; Hokken-Koelega AC
    Horm Res Paediatr; 2012; 77(3):170-9. PubMed ID: 22441140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth response to an individualized versus fixed dose GH treatment in short children born small for gestational age: the OPTIMA study.
    Jung H; Land C; Nicolay C; De Schepper J; Blum WF; Schönau E
    Eur J Endocrinol; 2009 Feb; 160(2):149-56. PubMed ID: 19039085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short children with low birth weight born either small for gestational age or average for gestational age show similar growth response and changes in insulin-like growth factor-1 to growth hormone treatment during the first prepubertal year.
    Ranke MB; Martin DD; Ehehalt S; Schwarze CP; Serra F; Wollmann HA; Schweizer R
    Horm Res Paediatr; 2011; 76(2):104-12. PubMed ID: 21757866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term efficacy and safety of two doses of growth hormone in short Japanese children born small for gestational age.
    Tanaka T; Yokoya S; Seino Y; Togari H; Mishina J; Kappelgaard AM; Fujieda K
    Horm Res Paediatr; 2011; 76(6):411-8. PubMed ID: 22156542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency.
    Sas T; Mulder P; Hokken-Koelega A
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3786-92. PubMed ID: 11061539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomised controlled trial evaluating IGF1 titration in contrast to current GH dosing strategies in children born small for gestational age: the North European Small-for-Gestational-Age Study.
    Jensen RB; Thankamony A; O'Connell SM; Kirk J; Donaldson M; Ivarsson SA; Söder O; Roche E; Hoey H; Dunger DB; Juul A
    Eur J Endocrinol; 2014 Oct; 171(4):509-18. PubMed ID: 25080293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study.
    Amant F; Van Calsteren K; Halaska MJ; Gziri MM; Hui W; Lagae L; Willemsen MA; Kapusta L; Van Calster B; Wouters H; Heyns L; Han SN; Tomek V; Mertens L; Ottevanger PB
    Lancet Oncol; 2012 Mar; 13(3):256-64. PubMed ID: 22326925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of IGF-1 in children born small for gestational age and with growth retardation, treated by growth hormone adapted to IGF-1 levels after 1 year.
    Cabrol S; Perin L; Colle M; Coutant R; Jésuran-Perelroizen M; Le Bouc Y; Czernichow P
    Horm Res Paediatr; 2011; 76(6):419-27. PubMed ID: 22156543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction model for adult height of small for gestational age children at the start of growth hormone treatment.
    de Ridder MA; Stijnen T; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2008 Feb; 93(2):477-83. PubMed ID: 18000093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study.
    Siemensma EP; Tummers-de Lind van Wijngaarden RF; Festen DA; Troeman ZC; van Alfen-van der Velden AA; Otten BJ; Rotteveel J; Odink RJ; Bindels-de Heus GC; van Leeuwen M; Haring DA; Oostdijk W; Bocca G; Mieke Houdijk EC; van Trotsenburg AS; Hoorweg-Nijman JJ; van Wieringen H; Vreuls RC; Jira PE; Schroor EJ; van Pinxteren-Nagler E; Willem Pilon J; Lunshof LB; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2307-14. PubMed ID: 22508707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.